FOLFOX has been shown to be highly effective in the treatment of colorectal cancer. Clinical trials have demonstrated that it can significantly improve overall survival and progression-free survival in patients with both early-stage and advanced colorectal cancer. For instance, in the adjuvant setting, FOLFOX has been found to reduce the risk of cancer recurrence and improve long-term survival rates.
